Literature DB >> 4714993

Synthesis and pharmacology of centrally acting dopamine derivatives qnd analogs in relation to parkinson's disease.

R J Borgman, J J Mcphillips, R E Stitzel, I J Goodman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4714993     DOI： 10.1021/jm00264a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  8 in total

1.  Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine.

Authors:  Lauri Peura; Kalle Malmioja; Kristiina Huttunen; Jukka Leppänen; Miia Hämäläinen; Markus M Forsberg; Mikko Gynther; Jarkko Rautio; Krista Laine
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

2.  Evaluation of mono- and dibenzoyl esters of dopamine as potential pro-drugs for dopamine in the central nervous system.

Authors:  S M Tejani-Butt; M Hauptmann; A D'Mello; A Frazer; J M Marcoccia; D J Brunswick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

3.  Simultaneous quantitative analysis of methamphetamine and 4-hydroxymethamphetamine in body fluids by gas chromatography/mass spectrometry.

Authors:  K Hara; M Kageura; Y Hieda; S Kashimura
Journal:  Z Rechtsmed       Date:  1988

Review 4.  Chemoselective O-acylation of hydroxyamino acids and amino alcohols under acidic reaction conditions: History, scope and applications.

Authors:  Tor E Kristensen
Journal:  Beilstein J Org Chem       Date:  2015-04-08       Impact factor: 2.883

Review 5.  Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.

Authors:  Fatma Haddad; Maryam Sawalha; Yahya Khawaja; Anas Najjar; Rafik Karaman
Journal:  Molecules       Date:  2017-12-25       Impact factor: 4.411

Review 6.  Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease.

Authors:  Nrupa Borkar; Huiling Mu; René Holm
Journal:  Asian J Pharm Sci       Date:  2017-12-06       Impact factor: 6.598

7.  NS3/4A helicase inhibitory alkaloids from Aptenia cordifolia as HCV target.

Authors:  Asmaa Abo Elgoud Said; Ahmed H Afifi; Taha F S Ali; Mamdouh Nabil Samy; Usama Ramadan Abdelmohsen; Mostafa A Fouad; Eman Zekry Attia
Journal:  RSC Adv       Date:  2021-10-06       Impact factor: 4.036

Review 8.  Antiparkinson prodrugs.

Authors:  Antonio Di Stefano; Piera Sozio; Laura Serafina Cerasa
Journal:  Molecules       Date:  2008-01-16       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.